New Insights Into Surgery Versus Stents For Diabetics With Multivessel Disease

Last year the large NHLBI FREEDOM trial demonstrated that bypass surgery was superior to PCI when treating diabetic patients who have multivessel coronary disease. CABG resulted in significant reductions in death and MI, but this was offset slightly by a higher rate of stroke in the CABG group. Now a new report from FREEDOM published in JAMA suggests that the reduction in important clinical endpoints may not translate into large differences in health status and quality of life.

Click here to read the full post on Forbes.

 

 

 

Leave a Reply

%d bloggers like this: